Menu Search
Equities

Izotropic Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
1R3:MUN

Izotropic Corp

Actions
  • Price (EUR)0.1365
  • Today's Change-0.004 / -2.85%
  • Shares traded3.00k
  • 1 Year change-28.46%
  • Beta2.5715
Data delayed at least 15 minutes, as of Feb 16 2026 08:05 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Izotropic Corporation is a Canada-based medical device company. The Company is engaged in commercializing imaging-based products utilizing emerging technologies for the more accurate screening, diagnoses, and treatment of breast cancers. Its lzoView computed tomography (CT) Imaging System is intended to produce cross-sectional images of anatomy that can be imaged in the 30 cm aperture by computer reconstruction of x-ray transmission data for non-invasive visualization of tissue. The IzoView is for use in the non-invasive visualization of breast tissue, as an adjunct tool to mammography, by providing x-ray computer reconstructed images as an aid for qualified healthcare providers. The Company has not generated any revenue.

  • Revenue in CAD (TTM)0.00
  • Net income in CAD-2.75m
  • Incorporated2016
  • Employees--
  • Location
    Izotropic CorpSuite 424, 800-15355 24th AvenueSURREY V4A 2H9CanadaCAN
  • Phone+1 (604) 542-9458
  • Fax+1 (604) 542-9458
  • Websitehttps://izocorp.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.